Article10.1007/s13277-015-3725-3
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models
Giovanni Luca Gravina,A. Mancini,Luca Scarsella,Alessandro Colapietro,Ana Jitariuc,Flora Vitale+3 more-2015-07-28-Tumor Biology
26
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
PI3K/AKT/mTOR pathwayPTENRPTORCancer researchProtein kinase BTensinProstate cancerCell growth
Chat
Click to start Chat